Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Prognostic Value of the Hevylite Chain in MGUS Patients in a Population Study

Aránzazu García Mateo, PhD, Maria-Victoria Mateos, MD PhD, Alberto Orfao, MD PhD, Teresa Contreras Sanfeliciano, Luzalba del Carmen Contreras Sanfeliciano, Mª Del Rosario Caro Narros, Noemi Puig, MD PhD, José Antonio Queizan, Carmen Olivier

Blood (2018) 132 (Supplement 1): 4506.

https://doi.org/10.1182/blood-2018-99-110329

Published: 2018

Journal Articles

Monoclonal Gammopathy of Undetermined Significance - Patient Characteristics and Referral Patterns

Holly Lee, MD, Lesley Street, MD, Jason Tay, MD, Jennifer Grossman, MD, John F Thaell, MD, Dawn Goodyear, MD, Sylvia McCulloch, MD, Peter Duggan, MD, Paola Neri, MD, Victor Jimenez-Zepeda, MD

Blood (2018) 132 (Supplement 1): 4496.

https://doi.org/10.1182/blood-2018-99-117930

Published: 2018

Journal Articles

Update on Severe Isotype-Matched Immunosuppression By Hevylite ® Confirms Its Predictive Value in MGUS Patients: A Real-Life Study

Juana Jimenez, MD, Nuno Barbosa, Tiago Moreira Pais, Maria Luisa Campos, Mª Antonia Peñálver, Carmen Hernando de Larramendi

Blood (2018) 132 (Supplement 1): 5583.

https://doi.org/10.1182/blood-2018-99-118212

Published: 2018

Journal Articles

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Blood (2017) 130 (Supplement 1): 5397.

https://doi.org/10.1182/blood.V130.Suppl_1.5397.5397

Published: 2017

Journal Articles

Severe Isotype-Matched Immunosuppression By Hevylite ® Is Predictive of Shorter Time to Progression in MGUS Patients

Juana Jiménez Jiménez, Tiago M Pais, PhD, Nuno Barbosa, Luisa Campos, Maria Antonia Peñalver, Carmen Hernando de Larramendi

Blood (2016) 128 (22): 4454.

https://doi.org/10.1182/blood.V128.22.4454.4454

Published: 2016

Journal Articles

Prognostic Impact Of Serum Heavy/Light Chain Pairs In Patients With MGUS and Smoldering Myeloma: Long-Term Results From a Single Institution

Carlos Fernández de Larrea, MD, PhD, Laura Magnano, MD, Montserrat Elena, MD, María Teresa Cibeira, MD, PhD, Natalia Tovar, MD, Juan I. Aróstegui, MD, PhD, Fabiola Pedrosa, MS, Laura Rosiñol, MD, Xavier Filella, MD, PhD, Jordi Yagüe, MD, PhD, Joan Bladé, MD, PhD

Blood (2013) 122 (21): 3132.

https://doi.org/10.1182/blood.V122.21.3132.3132

Published: 2013

Journal Articles

Serum Heavy Light Chain Immunoassays Compared To Traditional Serum Based Laboratory Testing For The Diagnosis and Screening Of Monoclonal Gammopathies

Qingli Wu, PhD, Deborah J. Kuhn, Ph.D.

Blood (2013) 122 (21): 5345.

https://doi.org/10.1182/blood.V122.21.5345.5345

Published: 2013

Journal Articles

A Novel Activating Mutation Of CXCR4 Plays a Crucial Role In Waldenstrom Macroglobulinemia Biology

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Cristina Jimenez, Patricia Maiso, PhD, Michele Moschetta, MD, Yuji Mishima, PhD, Michelle R. Kuhne, PhD, Pina M. Cardarelli, Ph.D., San Miguel Jesus F, MD PhD, Ramon Garcia-Sanz, Irene M. Ghobrial, MD

Blood (2013) 122 (21): 272.

https://doi.org/10.1182/blood.V122.21.272.272

Published: 2013

Journal Articles

Circulating B Cell Clones in Familial Waldenström Macroglobulinemia.

Mark C. Lanasa, MD, PhD, Sallie D. Allgood, MS, Lynn R. Goldin, PhD, Danielle M. Brander, MD, Mary L. McMaster, MD

Blood (2012) 120 (21): 2703.

https://doi.org/10.1182/blood.V120.21.2703.2703

Published: 2012

Journal Articles

Development of Myelodysplastic Syndrome and Acute Leukemias in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study of 17,315 Patients

Lindsey E. Roeker, Dirk Larson, Robert A. Kyle, MD, Shaji K. Kumar, MD, Angela Dispenzieri, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 934.

https://doi.org/10.1182/blood.V120.21.934.934

Published: 2012

Journal Articles

New Insights in the Pathogenesis of MGUS, Multiple Myeloma (MM) and Waldenström`s Macroglobulinemia (WM): Chronic Antigenic Stimulation by Autoantigenic Targets of Paraproteins Is Mediated by CD4 + t-Cells

Sandra Grass, MD, Klaus-Dieter Preuss, Aleksandra Wikowicz, Natalie Fadle, Evi Regitz, Gerhard Held, Leon Bernal-Mizrachi, MD, Sybille Raudies, Holger Thiele, Michael Pfreundschuh, MD, Frank Neumann

Blood (2011) 118 (21): 472.

https://doi.org/10.1182/blood.V118.21.472.472

Published: 2011

Journal Articles

Hyperphosphorylation of Antigenic Targets of Paraproteins In MGUS and Multiple Myeloma (MM) Is a Consistent Finding: Implications for the Pathogenesis of MGUS/MM

Sandra Grass, MD, Klaus-Dieter Preuss, Aleksandra Wikowicz, Natalie Fadle, Evi Regitz, Stephan D. Thome, MD, Henry T. Lynch, MD, Michael Pfreundschuh, MD

Blood (2010) 116 (21): 4085.

https://doi.org/10.1182/blood.V116.21.4085.4085

Published: 2010

Journal Articles

Immunoglobulin Heavy/Light Chain Ratios as An Alternative to Immunofixation In the Identification of Monoclonal Gammopathies

Anandram Seetharam, Tracy Lovatt, Alan Macwhannell, Abe Jacob, MD, FRCP, FRCPath, Sunil Honda, Stephen Harding, PhD, Supratik Basu

Blood (2010) 116 (21): 5018.

https://doi.org/10.1182/blood.V116.21.5018.5018

Published: 2010

Journal Articles

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Jerry Katzmann, PhD, Raynell Clark, Angela Dispenzieri, M.D., Robert Kyle, MD, Ola Landgren, M.D., Ph.D., Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD

Blood (2009) 114 (22): 1788.

https://doi.org/10.1182/blood.V114.22.1788.1788

Published: 2009

Journal Articles

IgG and IgA Monoclonal Gammopathies of Undetermined Significance (MGUS) at Low Risk of Evolution: Proposal and Validation of a Prognostic Scoring System

Francesca Gaia Rossi, MD, Luigi Marcheselli, Maria Teresa Petrucci, MD, Davide Rossi, Vincenzo Callea, MD, Andrea Guffanti, MD, Marianna De Muro, MD, Vincenzo Federico, MD, Anna Baraldi, M.D., Pellegrino Musto, MD, Andrea Bacigalupo, MD, Gianluca Gaidano, Maria Goldaniga, MD, Giuseppe Avvisati, Giorgio Lambertenghi Deliliers, MD, Luca Baldini, MD

Blood (2008) 112 (11): 5136.

https://doi.org/10.1182/blood.V112.11.5136.5136

Published: 2008

Journal Articles

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar, Ellen D. Remstein, Janice R. Offord, Dirk R. Larson, Matthew F. Plevak, L. Joseph Melton, III

Blood (2003) 102 (10): 3759–3764.

https://doi.org/10.1182/blood-2003-03-0801

Published: 2003

Journal Articles

Treatment of Acquired von Willebrand Syndrome in Patients With Monoclonal Gammopathy of Uncertain Significance: Comparison of Three Different Therapeutic Approaches

Augusto B. Federici, Federica Stabile, Giancarlo Castaman, Maria Teresa Canciani, Pier Mannuccio Mannucci

Blood (1998) 92 (8): 2707–2711.

https://doi.org/10.1182/blood.V92.8.2707

Published: 1998

NARROW

Prognostic Value of the Hevylite Chain in MGUS Patients in a Population Study

Monoclonal Gammopathy of Undetermined Significance - Patient Characteristics and Referral Patterns

Update on Severe Isotype-Matched Immunosuppression By Hevylite ® Confirms Its Predictive Value in MGUS Patients: A Real-Life Study

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Severe Isotype-Matched Immunosuppression By Hevylite ® Is Predictive of Shorter Time to Progression in MGUS Patients

Prognostic Impact Of Serum Heavy/Light Chain Pairs In Patients With MGUS and Smoldering Myeloma: Long-Term Results From a Single Institution

Serum Heavy Light Chain Immunoassays Compared To Traditional Serum Based Laboratory Testing For The Diagnosis and Screening Of Monoclonal Gammopathies

A Novel Activating Mutation Of CXCR4 Plays a Crucial Role In Waldenstrom Macroglobulinemia Biology

Circulating B Cell Clones in Familial Waldenström Macroglobulinemia.

Development of Myelodysplastic Syndrome and Acute Leukemias in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study of 17,315 Patients

New Insights in the Pathogenesis of MGUS, Multiple Myeloma (MM) and Waldenström`s Macroglobulinemia (WM): Chronic Antigenic Stimulation by Autoantigenic Targets of Paraproteins Is Mediated by CD4 + t-Cells

Hyperphosphorylation of Antigenic Targets of Paraproteins In MGUS and Multiple Myeloma (MM) Is a Consistent Finding: Implications for the Pathogenesis of MGUS/MM

Immunoglobulin Heavy/Light Chain Ratios as An Alternative to Immunofixation In the Identification of Monoclonal Gammopathies

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

IgG and IgA Monoclonal Gammopathies of Undetermined Significance (MGUS) at Low Risk of Evolution: Proposal and Validation of a Prognostic Scoring System

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

Treatment of Acquired von Willebrand Syndrome in Patients With Monoclonal Gammopathy of Uncertain Significance: Comparison of Three Different Therapeutic Approaches

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only